Cart
sales@molnova.com
Cevidoplenib dimesylate hydrochloride
CAS No. 269062-93-3
Cevidoplenib dimesylate hydrochloride( Cevidoplenib dimesylate hydrochloride(2043659-93-2 Free base) )
Catalog No. M28906 CAS No. 269062-93-3
Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 223 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 597 | Get Quote |
|
| 50MG | 851 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | 2313 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCevidoplenib dimesylate hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
-
DescriptionCevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.(In Vitro):Cevidoplenib dimesylate hydrochloride(oral) inhibited the activity of SYK and blocked Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, mast cells, natural killer cells, B cells, and neutrophils.
-
In Vitro——
-
In Vivo——
-
SynonymsCevidoplenib dimesylate hydrochloride(2043659-93-2 Free base)
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorAdenylyl cyclase (AC)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number269062-93-3
-
Formula Weight1957.9
-
Molecular FormulaC90H132Cl5N27O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCCC[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H]3N(C([C@H](CC4=CNC5=C4C=CC=C5)NC([C@H](CC6=CNC7=C6C=CC=C7)NC([C@H]8N(C([C@H](CC9=CNC%10=C9C=CC=C%10)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H]([C@@H](C)CC)N)=
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ramos-Espiritu L, et al. Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase. Nat Chem Biol. 2016 Oct;12(10):838-44.
molnova catalog
related products
-
Sovleplenib
Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopenia (ITP).
-
Amylmetacresol
Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
-
Cis-ACBD
2, 4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist.
